The growth was led by family-owned companies and business groups with presence in pharmaceuticals, information technology services, and consumer products.
'What kind of education have we had if we can't treat another human being with equal respect?'
If the government of India is indeed interested in an amicable solution, instead of proposing half-hearted steps such as putting the laws on hold for 18 months, it can withdraw the legislations and think of other possible solutions, given the basic constitutional position that the subject of agriculture is in the State list in the Constitution, it said.
The S&P BSE 500 index, which accounts for 94% market capitalisation of BSE listed companies, has gained 45% from its March 24 low. However, out of the BSE 500 index stocks, 225 have underperformed the index by gaining less than the broader index during this period.
TMC MP Professor Sugata Bose spoke eloquently on the topic of nationalism vs the freedom to dissent, whilst presenting a balanced view on the need to protect constitutional freedoms.
Ajit Mishra, vice president, Research, Religare Broking, answers your queries.
Ajit Mishra, vice president, Research, Religare Broking, answers your stock market queries.
The smog reduced the visibility to merely 300 meters in the morning affecting traffic, an official of the India Meteorological Department said.
'They are our go-to men, our trouble-shooters.' 'They draw their strength from remaining low-key and accessible only to our workers.'
Auto, pharma, IT, chemicals among sectors with significant reliance on UK and European nations with Tata Motors, Motherson Sumi, Tata Steel, TCS, Wipro, Infosys and Tech M among key names.
Better-than-expected financial results in Q3 due to higher revenue growth and margins in key markets fuel the rally
Indian companies have made acquisitions of $1 billion so far in January
Companies run till now by mostly their promoters are increasingly inducting professionals to head their teams.
With an m-cap of Rs 31,744 crore, IRCTC stood at 96th position in the overall market capitalisation ranking, the BSE data shows.
USFDA has extended the timeline for granting tentative approval to generic drug applications filed under Para IV of its rules by 10 months.
Vajpayee's last rites will be performed at the Rashtriya Smriti Sthal in New Delhi at 4 pm on Friday.
Global investment firm Citigroup is bullish on Indian equity markets.
Adani Power will also be dropped from the S&P BSE 100 index
In a reprieve for controversial United States historian Peter Heehs who faced deportation from India, the Union home ministry on Friday extended his visa by one more year with effect from April 15.
The upside for Ranbaxy Laboratories is likely to continue even as it loses its 180 days of marketing exclusivity for the Lipitor generic in the American market.
'May it be the guardian which calls for breaking down narrow walls of the mind.' 'May it continue to invite everyone to celebrate the possibilities of humanity's one-ness.' Claude Arpi salutes 50 years of Auroville, a Grand Experiment in Living.
Ajit Mishra, vice president, Research, Religare Broking, answers readers' queries on stocks they own or want to buy.
Ahmad, a waiter by profession, was on his scooter with two of his friends riding pillion driving past Lajpat Nagar in the wee hours on Tuesday when the speeding truck hit them from behind, a police official said.
European countries are trying to woo back the Indian customers they had lost following seizure of drug consignments by Customs authorities of several European Union members.
Ajit Mishra, vice president, Research, Religare Broking, answers your queries.
S&P BSE Sensex settled at 31,170, up 60 points, while the broader Nifty50 closed at record high for third straight session. It ended at 9,624, up 19 points.
Ajit Mishra, vice president, Research, Religare Broking, answers your queries.
Drugmaker Aurobindo Pharma on Monday said it has entered into licensing and supply agreements with London-based pharmaceutical giant AstraZeneca to supply several solid dosage and sterile products for emerging markets.
The anti-depressant drug market in the US is primarily ruled by Effexor XR (Venlafaxine) of Wyeth (now owned by Pfizer).
Omkeshwar Singh, head, Rank MF, a mutual fund investment platform, answers your queries.
The rupee's appreciation of 6.4 per cent against the dollar and 12 per cent against the euro is likely to hurt the first-quarter performance of the pharmaceutical sector, indicate a results' preview by broking houses.
But the newer entrants prove nimbler than the slowing pioneers.
Sanjeev Nayyar offers a roster of things to do to see the India of our dreams.
Ajit Mishra, vice president, Research, Religare Broking, answers your queries.
Here's the full text of President's Ram Nath Kovind's address to the joint sitting of both houses of Parliament on the first of Budget Session 2022.
Year 2008 results of India's largest drug maker, Ranbaxy Laboratories, and Wockhardt were also impacted by forex losses. Companies such as Aurobindo and Orchid are also expected to post forex losses, say analysts.
This increase is despite the decreased growth of drug sales in the US - the world's largest market - which has seen a tightening of regulations and aggressive competition.
GlaxoSmithKline Plc's anti-migraine drug brand, Imitrex, is turning out to be a good revenue earner for Indian generic companies.
India emerging as a big global destination for contract manufacturing, unlike R&D outsourcing.
Gaurav Garg, Head of Research, CapitalVia answers readers' stock market queries
© 2026 Rediff.com - Investor Information - Advertise with us - Disclaimer - Privacy Policy - Sitemap - Feedback - About us - Terms of use - Grievances